Ultragenyx Pharmaceutical Inc. Business Finance Contracts & Agreements
38 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (4)
- Stock Agreements (17)
- Underwriting Agreements (9)
- Warrant Agreements (7)
- Form of Pre-Funded Warrant (Filed With SEC on June 17, 2024)
- Underwriting Agreement, dated as of June 13, 2024, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and TD... (Filed With SEC on June 17, 2024)
- Form of Restricted Stock Unit Agreement (Grant for New Directors) (2023 Plan) (Filed With SEC on February 21, 2024)
- Form of Non-Statutory Stock Option Agreement (Grant for New Directors)(2023 Plan) (Filed With SEC on February 21, 2024)
- Form of Restricted Stock Unit Agreement (Annual Grant for Directors) (2023 Plan) (Filed With SEC on February 21, 2024)
- Form of Non-Statutory Stock Option Agreement (Annual Grant for Directors) (2023 Plan) (Filed With SEC on February 21, 2024)
- Form of Restricted Stock Unit Agreement (Employees)(2023 Plan) (Filed With SEC on February 21, 2024)
- Form of Non Statutory Stock Option Agreement (Employees)(2023 Plan) (Filed With SEC on February 21, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on October 23, 2023)
- Underwriting Agreement, dated as of October 18, 2023, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and... (Filed With SEC on October 23, 2023)
- Royalty Purchase Agreement by and among Rare Delaware Inc., Ultragenyx Pharmaceutical Inc. and OCM LS23 Holdings LP dated as of July 14, 2022 (Filed With SEC on July 29, 2022)
- Form of Restricted Stock Unit Agreement (Grant for New Directors) (Filed With SEC on August 3, 2021)
- Form of Non-Statutory Stock Option Agreement (Grant for New Directors) (Filed With SEC on August 3, 2021)
- Form of Restricted Stock Unit Agreement (Annual Grant for Directors) (Filed With SEC on August 3, 2021)
- Form of Non-Statutory Stock Option Agreement (Annual Grant for Directors) (Filed With SEC on August 3, 2021)
- Form of Restricted Stock Unit Agreement (Inducement Plan)(ex-US) (Filed With SEC on February 12, 2021)
- Form of Restricted Stock Unit Agreement (Inducement Plan) (Filed With SEC on February 12, 2021)
- Form of Non Statutory Stock Option Agreement (Inducement Plan) (ex-US) (Filed With SEC on February 12, 2021)
- Form of Non Statutory Stock Option Agreement (Inducement Plan) (Filed With SEC on February 12, 2021)
- Underwriting Agreement, dated as of October 28, 2020, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, BofA Securities, Inc., and... (Filed With SEC on November 2, 2020)
- Equity Purchase Agreement, dated as of June 18, 2019 by and among Ultragenyx Pharmaceutical Inc. and Arcturus Therapeutics Ltd (Filed With SEC on July 31, 2020)
- Royalty Purchase Agreement, dated as of December 17, 2019, between Ultragenyx Pharmaceutical Inc. and RPI Finance Trust (Filed With SEC on February 14, 2020)
- Description of Common Stock (Filed With SEC on February 14, 2020)
- Underwriting Agreement, dated as of February 26, 2019, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Merrill Lynch, Pierce, Fenner... (Filed With SEC on March 1, 2019)
- Asset Purchase Agreement, dated December 14, 2017, among Ultragenyx Pharmaceutical Inc., Ultragenyx International UX003 Ltd. and Novartis Pharma AG (Filed With SEC on February 21, 2018)
- Underwriting Agreement, dated as of January 23, 2018, among Ultragenyx Pharmaceutical Inc. and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated,... (Filed With SEC on January 26, 2018)
- ULTRAGENYX PHARAMACEUTICAL INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (amended as of June 9, 2016) (Filed With SEC on February 17, 2017)
- ULTRAGENYX PHARMACEUTICAL INC. 2,200,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on July 21, 2015)
- ULTRAGENYX PHARMACEUTICAL INC. 3,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 10, 2015)
- ULTRAGENYX PHARMACEUTICAL INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on July 7, 2014)
- ULTRAGENYX PHARAMACEUTICAL INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 17, 2014)
- ULTRAGENYX PHARMACEUTICAL INC. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on January 17, 2014)
- ULTRAGENYX PHARMACEUTICAL INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT Dated as of December 18, 2012 TABLE OF CONTENTS (Filed With SEC on November 8, 2013)
- WARRANT TO PURCHASE SERIES A PREFERRED STOCK OF ULTRAGENYX PHARMACEUTICAL INC. (Filed With SEC on November 8, 2013)
- WARRANT TO PURCHASE SERIES A PREFERRED STOCK OF ULTRAGENYX PHARMACEUTICAL INC. (Filed With SEC on November 8, 2013)
- WARRANT TO PURCHASE SERIES A PREFERRED STOCK OF ULTRAGENYX PHARMACEUTICAL INC. (Filed With SEC on November 8, 2013)
- WARRANT TO PURCHASE SERIES A PREFERRED STOCK OF ULTRAGENYX PHARMACEUTICAL INC. (Filed With SEC on November 8, 2013)
- WARRANT TO PURCHASE SERIES A PREFERRED STOCK OF ULTRAGENYX PHARMACEUTICAL INC. (Filed With SEC on November 8, 2013)
